By Laura Lutz
Des Moines, Aug. 8 - Oragenics, Inc. completed a private placement of shares for $1.17 million.
Most of the shares involved in the placement were priced at $0.25 each. About 110,000 of the shares were bought by Oragenic's newly appointed director, Ronald P. Evens, and were priced at $0.44 each.
In total, 4.6 million shares were sold in the deal.
Investors also received warrants for an equal number of shares. The warrants are exercisable at $0.58 per share for one year.
Proceeds will be used for clinical development of the company's technologies and for general corporate purposes.
Oragenics is a biopharmaceutical company based in Alachua, Fla.
| Issuer: | Oragenics, Inc.
|
| Issue: | Common shares
|
| Amount: | $1.17 million
|
| Shares: | 4.6 million
|
| Price: | $0.25 (for most); $0.44 (for about 110,000 shares)
|
| Warrants: | For 4.6 million shares
|
| Warrant expiration: | One year
|
| Warrant strike price: | $0.58
|
| Investor: | Ronald P. Evens (for about 110,000 shares)
|
| Settlement date: | Aug. 8
|
| Stock symbol: | Amex: ONI
|
| Stock price: | $0.44 at close Aug. 7
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
